{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:16:10Z","timestamp":1792736170903,"version":"4.5.0"},"reference-count":279,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000066","name":"NIEHS","doi-asserted-by":"publisher","award":["R44ES026909"],"award-info":[{"award-number":["R44ES026909"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Toxicology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.comtox.2021.100191","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T12:14:32Z","timestamp":1632399272000},"page":"100191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["In silico approaches in carcinogenicity hazard assessment: Current status and future needs"],"prefix":"10.1016","volume":"20","author":[{"given":"Raymond R.","family":"Tice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Amberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart T.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Bellion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romualdo","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Birmingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Brigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bringezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ceriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Elespuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Frericks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga H.J.","family":"Gerets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria D.","family":"Jahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi L.","family":"Kruhlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Lo","family":"Piparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lopez-Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjit","family":"Luniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Madia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Mestres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Mihalchik-Burhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Pandiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia V.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Trejo-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Watanabe-Sailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn J.","family":"Myatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.comtox.2021.100191_b0005","unstructured":"WHO, World Health Organization Cancer Fact Sheet, (2020). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer (accessed October 20, 2020)."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0010","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1096\/fasebj.5.9.1860619","article-title":"Facts and theories concerning the mechanisms of carcinogenesis","volume":"5","author":"Pitot","year":"1991","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0273-2300(03)00071-0","article-title":"Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices","volume":"38","author":"Contrera","year":"2003","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0020","doi-asserted-by":"crossref","unstructured":"D. Guo, N.L. Kruhlak, L. Stavitskaya, K.P. Cross, D.A. Bower, Characterizing compound classes by rodent carcinogenicity tumor severity and type, in: Baltimore, MD, 2016. https:\/\/doi.org\/10.1177\/1091581816686042.","DOI":"10.1177\/1091581816686042"},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2005.11.003","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yrtph.2005.10.004","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0035","article-title":"Validating (Q)SAR models to predict rodent carcinogenicity","author":"Kruhlak","year":"2020","journal-title":"in"},{"key":"10.1016\/j.comtox.2021.100191_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2018.04.014","article-title":"In silico toxicology protocols","volume":"96","author":"Myatt","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0045","doi-asserted-by":"crossref","first-page":"104403","DOI":"10.1016\/j.yrtph.2019.104403","article-title":"Genetic toxicology in silico protocol","volume":"107","author":"Hasselgren","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0050","doi-asserted-by":"crossref","first-page":"104688","DOI":"10.1016\/j.yrtph.2020.104688","article-title":"Skin sensitization in silico protocol","volume":"116","author":"Johnson","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.comtox.2021.100191_b0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1289\/ehp.1509912","article-title":"Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis","volume":"124","author":"Smith","year":"2016","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.comtox.2021.100191_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2017.01.020","article-title":"Improving the International Agency for Research on Cancer\u2019s consideration of mechanistic evidence","volume":"319","author":"Goodman","year":"2017","journal-title":"Toxicol Appl Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0065","article-title":"Evidence on the carcinogenicity of acetaminophen","volume":"65","author":"OEHHA,","year":"2019","journal-title":"Reproductive and cancer hazard assessment branch office of environmental health hazard assessment California environmental protection agency"},{"key":"10.1016\/j.comtox.2021.100191_b0070","doi-asserted-by":"crossref","first-page":"104859","DOI":"10.1016\/j.yrtph.2020.104859","article-title":"Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential","volume":"120","author":"Jaeschke","year":"2021","journal-title":"Regul Toxicol Pharmacol."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b0075","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/cr100222q","article-title":"Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology","volume":"111","author":"Benigni","year":"2011","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.comtox.2021.100191_b0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3109\/10408444.2010.494175","article-title":"A review of the electrophilic reaction chemistry involved in covalent DNA binding","volume":"40","author":"Enoch","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0085","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z","article-title":"Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer."},{"key":"10.1016\/j.comtox.2021.100191_b0090","doi-asserted-by":"crossref","unstructured":"OECD, Fundamental and Guiding Principles for (Q)SAR Analysis of Chemical Carcinogens with Mechanistic Considerations, OECD Environment, Health and Safety Publications, Paris, 2015. https:\/\/doi.org\/10.1787\/9789264274792-en.","DOI":"10.1787\/9789264274792-en"},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/mi.10.1.7","article-title":"Signaling actions of electrophiles: anti-inflammatory therapeutic candidates","volume":"10","author":"Groeger","year":"2010","journal-title":"Mol. Interventions."},{"key":"10.1016\/j.comtox.2021.100191_b0100","doi-asserted-by":"crossref","unstructured":"R. Kemper, M. Taub, M. Bogdanffy, Metabolism: a determinant of toxicity, in: A. Hayes, C. Kruger (Eds.), Hayes\u2019 Principles and Methods of Toxicology, Sixth Edition, CRC Press, London, 2014: pp. 141\u2013214. https:\/\/doi.org\/10.1201\/b17359.","DOI":"10.1201\/b17359-6"},{"key":"10.1016\/j.comtox.2021.100191_b0105","series-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons","first-page":"189","article-title":"Chemical carcinogenesis","author":"Klaunig","year":"2013"},{"key":"10.1016\/j.comtox.2021.100191_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tox.2019.02.005","article-title":"Mechanisms of soft and hard electrophile toxicities","volume":"418","author":"LoPachin","year":"2019","journal-title":"Toxicology."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ht7020012","article-title":"Reactive chemicals and electrophilic stress in cancer: a minireview","volume":"7","author":"Sakanyan","year":"2018","journal-title":"High-Throughput."},{"issue":"10","key":"10.1016\/j.comtox.2021.100191_b0120","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1158\/1055-9965.EPI-19-1346","article-title":"The key characteristics of carcinogens: relationship to the hallmarks of cancer, relevant biomarkers, and assays to measure them, Cancer Epidemiol","volume":"29","author":"Smith","year":"2020","journal-title":"Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1218(88)90114-0","article-title":"Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI\/NTP","volume":"204","author":"Ashby","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.comtox.2021.100191_b0130","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1016\/S1452-3981(23)19583-6","article-title":"A simple and robust model for predicting the reduction potential of quinones family: Electrophilicity index effect","volume":"7","author":"Beheshti","year":"2012","journal-title":"Int. J. Electrochem. Sci."},{"issue":"10","key":"10.1016\/j.comtox.2021.100191_b0135","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/tx100172x","article-title":"Prediction of Michael-type acceptor reactivity toward glutathione","volume":"23","author":"Schw\u00f6bel","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2016.02.003","article-title":"Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity","volume":"77","author":"Ahlberg","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00894-015-2608-2","article-title":"On the intrinsic reactivity index for electrophilicity\/nucleophilicity responses","volume":"21","author":"Chamorro","year":"2015","journal-title":"J. Mol. Model."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0150","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/ja983494x","article-title":"Electrophilicity index","volume":"121","author":"Parr","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.comtox.2021.100191_b0155","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.3390\/ijms12085098","article-title":"Implications for electrophilic theory of chemical carcinogenesis","volume":"12","author":"Putz","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11030-005-9009-x","article-title":"Analyzing toxicity through electrophilicity","volume":"10","author":"Roy","year":"2006","journal-title":"Mol. Diversity."},{"issue":"06","key":"10.1016\/j.comtox.2021.100191_b0165","doi-asserted-by":"crossref","DOI":"10.4172\/jbb.1000356","article-title":"Molecular electrophilicity index - A promising descriptor for predicting toxicological property","volume":"09","author":"H","year":"2017","journal-title":"J. Bioequivalence Bioavailability."},{"key":"10.1016\/j.comtox.2021.100191_b0170","doi-asserted-by":"crossref","unstructured":"J.A.H. Schw\u00f6bel, Y.K. Koleva, S.J. Enoch, F. Bajot, M. Hewitt, J.C. Madden, D.W. Roberts, T.W. Schultz, M.T.D. Cronin, Measurement and estimation of electrophilic reactivity for predictive toxicology, Chem. Rev. 111 (2011) 2562\u20132596. https:\/\/doi.org\/10.1021\/cr100098n.","DOI":"10.1021\/cr100098n"},{"key":"10.1016\/j.comtox.2021.100191_b0175","series-title":"Jrc","author":"Ec","year":"2020"},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0180","doi-asserted-by":"crossref","DOI":"10.2903\/sp.efsa.2019.EN-1598","article-title":"Evaluation of the applicability of existing (Q)SAR models for predicting the genotoxicity of pesticides and similarity analysis related with genotoxicity of pesticides for facilitating of grouping and read across","volume":"16","author":"Benigni","year":"2019","journal-title":"EFSA Supporting Publications."},{"key":"10.1016\/j.comtox.2021.100191_b0185","article-title":"M7 (R1) Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk","author":"ICH","year":"2017","journal-title":"European Medicines Agency"},{"key":"10.1016\/j.comtox.2021.100191_b0190","doi-asserted-by":"crossref","first-page":"104488","DOI":"10.1016\/j.yrtph.2019.104488","article-title":"Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses","volume":"109","author":"Landry","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0195","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","article-title":"MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist","volume":"48","author":"Cruciani","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.comtox.2021.100191_b0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","journal-title":"J. Cheminf."},{"issue":"15","key":"10.1016\/j.comtox.2021.100191_b0205","first-page":"1907","article-title":"Computational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and software, Future","volume":"4","author":"Peach","year":"2012","journal-title":"Med. Chem."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/cbdd.13445","article-title":"Computational methods and tools to predict cytochrome P450 metabolism for drug discovery","volume":"93","author":"Tyzack","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.comtox.2021.100191_b0215","series-title":"RSC Drug Discovery","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1039\/9781849733410-00279","article-title":"Chapter 11. Expert systems: the use of expert systems in drug design-toxicity and metabolism","author":"Long","year":"2011"},{"key":"10.1016\/j.comtox.2021.100191_b0220","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2174\/1381612043452596","article-title":"A systematic approach to simulating metabolism in computational toxicology. I. the TIMES heuristic modelling framework","volume":"10","author":"Mekenyan","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/ml100016x","article-title":"SMARTCyp: A 2D method for prediction of cytochrome P450-mediated drug metabolism","volume":"1","author":"Rydberg","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.comtox.2021.100191_b0230","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/bioinformatics\/btq584","article-title":"The SMARTCyp cytochrome P450 metabolism prediction server","volume":"26","author":"Rydberg","year":"2010","journal-title":"Bioinformatics."},{"issue":"6009","key":"10.1016\/j.comtox.2021.100191_b0235","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.comtox.2021.100191_b0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-4598-10-54","article-title":"The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors","volume":"10","author":"Stehr","year":"2011","journal-title":"Mol. Cancer."},{"issue":"7-8","key":"10.1016\/j.comtox.2021.100191_b0245","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/10937404.2019.1643536","article-title":"Key characteristics of 86 agents known to cause cancer in humans","volume":"22","author":"Krewski","year":"2019","journal-title":"J. Toxicol. Environ. Health, Part B"},{"key":"10.1016\/j.comtox.2021.100191_b0250","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 471: Bacterial Reverse Mutation Test, OECD Publishing, Paris, 1997. https:\/\/doi.org\/10.1787\/9789264071247-en.","DOI":"10.1787\/9789264071247-en"},{"key":"10.1016\/j.comtox.2021.100191_b0255","doi-asserted-by":"crossref","unstructured":"EFSA PPR, Guidance on the establishment of the residue definition for dietary risk assessment, EFSA J. 14 (2016) 4549. https:\/\/doi.org\/10.2903\/j.efsa.2016.4549.","DOI":"10.2903\/j.efsa.2016.4549"},{"key":"10.1016\/j.comtox.2021.100191_b0260","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 490: In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene, OECD Publishing, Paris, 2016. https:\/\/doi.org\/10.1787\/9789264264908-en.","DOI":"10.1787\/9789264264908-en"},{"key":"10.1016\/j.comtox.2021.100191_b0265","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 476: In Vitro Mammalian Cell Gene Mutation Tests using the Hprt and xprt genes, OECD Publishing, 2016. https:\/\/doi.org\/10.1787\/9789264264809-en.","DOI":"10.1787\/9789264264809-en"},{"key":"10.1016\/j.comtox.2021.100191_b0270","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 487: In Vitro Mammalian Cell Micronucleus Test, OECD Publishing, Paris, 2016. https:\/\/doi.org\/10.1787\/9789264264861-en.","DOI":"10.1787\/9789264264861-en"},{"key":"10.1016\/j.comtox.2021.100191_b0275","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 474: Mammalian Erythrocyte Micronucleus Test, OECD Publishing, Paris, 2016. https:\/\/doi.org\/10.1787\/9789264264762-en.","DOI":"10.1787\/9789264264762-en"},{"key":"10.1016\/j.comtox.2021.100191_b0280","doi-asserted-by":"crossref","first-page":"104620","DOI":"10.1016\/j.yrtph.2020.104620","article-title":"Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay","volume":"113","author":"Yoo","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0285","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays, OECD Publishing, Paris, 2020. https:\/\/doi.org\/10.1787\/9789264203907-en.","DOI":"10.1787\/9789264203907-en"},{"key":"10.1016\/j.comtox.2021.100191_b0290","unstructured":"OECD, The in vivo erythrocyte Pig-a gene mutation assay - Part 1 - Detailed review paper and performance assessment, OECD Environment, Health and Safety Publications, Paris, 2020. http:\/\/www.oecd.org\/chemicalsafety\/testing\/series-testing-assessment-publications-number.htm."},{"key":"10.1016\/j.comtox.2021.100191_b0295","unstructured":"OECD, The in vivo erythrocyte Pig-a gene mutation assay - Part 2 - Validation report, OECD Environment, Health and Safety Publications, Paris, 2020. http:\/\/www.oecd.org\/chemicalsafety\/testing\/series-testing-assessment-publications-number.htm."},{"key":"10.1016\/j.comtox.2021.100191_b0300","doi-asserted-by":"crossref","unstructured":"B.B. Gollapudi, A.M. Lynch, R.H. Heflich, S.D. Dertinger, V.N. Dobrovolsky, R. Froetschl, K. Horibata, M.O. Kenyon, T. Kimoto, D.P. Lovell, L.F. Stankowski, P.A. White, K.L. Witt, J.Y. Tanir, The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup, Mutat. Res., Genet. Toxicol. Environ. Mutagen. 783 (2015) 23\u201335. https:\/\/doi.org\/10.1016\/j.mrgentox.2014.09.007.","DOI":"10.1016\/j.mrgentox.2014.09.007"},{"key":"10.1016\/j.comtox.2021.100191_b0305","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 489: In Vivo Mammalian Alkaline Comet Assay, OECD Publishing, Paris, 2016. https:\/\/doi.org\/10.1787\/9789264264885-en.","DOI":"10.1787\/9789264264885-en"},{"issue":"10","key":"10.1016\/j.comtox.2021.100191_b0310","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/1087057112453312","article-title":"Development of a high-throughput Gaussia Luciferase reporter assay for the activation of the GADD45a gene by mutagens, promutagens, clastogens, and aneugens","volume":"17","author":"Hughes","year":"2012","journal-title":"J. Biomol. Screening."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/s468","article-title":"Chromosomal aberrations clastogens vs aneugens","volume":"9","author":"Mishima","year":"2017","journal-title":"Front. Biosci."},{"issue":"14","key":"10.1016\/j.comtox.2021.100191_b0320","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1073\/pnas.1114278109","article-title":"High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death","volume":"109","author":"Fox","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.comtox.2021.100191_b0325","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/em.22112","article-title":"Assessment of the DNA damaging potential of environmental chemicals using a quantitative high-throughput screening approach to measure p53 activation","volume":"58","author":"Witt","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b0330","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/14622416.6.4.419","article-title":"Gene expression profile analysis: An emerging approach to investigate mechanisms of genotoxicity","volume":"6","author":"Aubrecht","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.comtox.2021.100191_b0335","series-title":"Validation of Alternative Methods for Toxicity Testing","first-page":"243","article-title":"Validation of transcriptomics-based in vitro methods","author":"Corvi","year":"2016"},{"issue":"51","key":"10.1016\/j.comtox.2021.100191_b0340","doi-asserted-by":"crossref","first-page":"E10881","DOI":"10.1073\/pnas.1714109114","article-title":"Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.comtox.2021.100191_b0345","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/em.21941","article-title":"Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells","volume":"56","author":"Li","year":"2015","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.comtox.2021.100191_b0350","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tox.2013.10.009","article-title":"Utilization of CDKN1A\/p21 gene for class discrimination of DNA damage-induced clastogenicity","volume":"315","author":"Sakai","year":"2014","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0355","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/toxsci\/kfv323","article-title":"The extended ToxTracker assay discriminates between induction of DNA damage, oxidative Stress, and protein misfolding","volume":"150","author":"Hendriks","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0360","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/em.22342","article-title":"Next-generation genotoxicology: using modern sequencing technologies to assess somatic mutagenesis and cancer risk","volume":"61","author":"Salk","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.comtox.2021.100191_b0365","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/toxsci\/kfx235","article-title":"Investigating the generalizability of the MultiFlow\u00ae DNA damage assay and several companion machine learning models with a set of 103 diverse test chemicals","volume":"162","author":"Bryce","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0370","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/em.22130","article-title":"Classification of in vitro genotoxicants using a novel multiplexed biomarker assay compared to the flow cytometric micronucleus test: classification of in vitro genotoxicants","volume":"58","author":"Wilde","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-genet-111212-133232","article-title":"Causes of genome instability","volume":"47","author":"Aguilera","year":"2013","journal-title":"Annu. Rev. Genet."},{"issue":"12","key":"10.1016\/j.comtox.2021.100191_b0380","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.clon.2018.09.001","article-title":"Science in focus: genomic instability and its implications for clinical cancer care","volume":"30","author":"Ahmad","year":"2018","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0385","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-012615-044446","article-title":"Mechanisms and consequences of cancer genome instability: lessons from genome sequencing studies","volume":"11","author":"Lee","year":"2016","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"10.1016\/j.comtox.2021.100191_b0390","first-page":"1000165","article-title":"Genomic instability and cancer","volume":"5","author":"Yao","year":"2014","journal-title":"J. Carcinog. Mutagen."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b0395","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.comtox.2021.100191_b0400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cr.2007.113","article-title":"A brief history of the DNA repair field","volume":"18","author":"Friedberg","year":"2008","journal-title":"Cell Res."},{"issue":"15-16","key":"10.1016\/j.comtox.2021.100191_b0410","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/15287394.2011.582320","article-title":"Assays to determine DNA repair ability","volume":"74","author":"Valdiglesias","year":"2011","journal-title":"J. Toxicol. Environ. Health Part A."},{"key":"10.1016\/j.comtox.2021.100191_b0415","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.3892\/ol.2017.6002","article-title":"Strategies for the evaluation of DNA damage and repair mechanisms in cancer","volume":"13","author":"Figueroa-Gonz\u00e1lez","year":"2017","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.comtox.2021.100191_b0420","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ctrv.2009.06.005","article-title":"Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance","volume":"35","author":"Zhu","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.comtox.2021.100191_b0425","unstructured":"IARC, Tumour site concordance and mechanisms of carcinogenesis, WHO Press, Switzerland, 2019. https:\/\/publications.iarc.fr\/_publications\/media\/download\/5592\/a0d74b9a500b62a4fb6d2ee6c2926b54b82cb9dc.pdf."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0430","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/carcin\/bgt212","article-title":"Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation","volume":"34","author":"Herceg","year":"2013","journal-title":"Carcinogenesis"},{"issue":"7-8","key":"10.1016\/j.comtox.2021.100191_b0435","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/10937404.2019.1642593","article-title":"Development of a database on key characteristics of human carcinogens","volume":"22","author":"Al-Zoughool","year":"2019","journal-title":"J. Toxicol. Environ. Health, Part B"},{"key":"10.1016\/j.comtox.2021.100191_b0440","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1038\/s41598-020-59260-4","article-title":"DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer","volume":"10","author":"Beetch","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b0445","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ijc.31014","article-title":"Roadmap for investigating epigenome deregulation and environmental origins of cancer","volume":"142","author":"Herceg","year":"2018","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.comtox.2021.100191_b0450","series-title":"IASLC Thoracic Oncology (Second Edition)","first-page":"95","article-title":"11 - Mutational Events in Lung Cancer: Present and Developing Technologies","author":"Morgensztern","year":"2018"},{"key":"10.1016\/j.comtox.2021.100191_b0455","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cotox.2017.08.004","article-title":"Role of epigenetics in tumor induction by non-genotoxic carcinogens","volume":"6","author":"Tryndyak","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0460","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cotox.2017.06.007","article-title":"Epigenetics in chemical-induced genotoxic carcinogenesis","volume":"6","author":"Chappell","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mrrev.2016.03.004","article-title":"Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review","volume":"768","author":"Chappell","year":"2016","journal-title":"Mutat. Res., Rev. Mutat. Res."},{"key":"10.1016\/j.comtox.2021.100191_b0470","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semcancer.2019.01.002","article-title":"Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis","volume":"57","author":"Wang","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.comtox.2021.100191_b0475","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.fct.2017.08.030","article-title":"Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?","volume":"109","author":"Dusinska","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0480","doi-asserted-by":"crossref","first-page":"445","DOI":"10.14573\/altex.2013.4.445","article-title":"In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors","volume":"30","author":"Greally","year":"2013","journal-title":"ALTEX"},{"key":"10.1016\/j.comtox.2021.100191_b0485","first-page":"359","article-title":"International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances","volume":"33","author":"Jacobs","year":"2016","journal-title":"ALTEX"},{"key":"10.1016\/j.comtox.2021.100191_b0490","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12967-017-1218-4","article-title":"The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications","volume":"15","author":"Ren","year":"2017","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.comtox.2021.100191_b0495","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00204-020-02784-5","article-title":"Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens","volume":"94","author":"Jacobs","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0500","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/ijms18061179","article-title":"A Tox21 approach to altered epigenetic landscapes: assessing epigenetic toxicity pathways leading to altered gene expression and oncogenic transformation in vitro","volume":"18","author":"Parfett","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b0505","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/cr300206t","article-title":"Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts","volume":"113","author":"Benigni","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.comtox.2021.100191_b0510","series-title":"Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens","article-title":"Mechanisms of action of chemical carcinogens and their role in structure\u2013activity relationships (SAR) analysis and risk assessment","author":"Woo","year":"2003"},{"key":"10.1016\/j.comtox.2021.100191_b0515","doi-asserted-by":"crossref","unstructured":"R. Aguayo-Ortiz, E. Fern\u00e1ndez-de Gortari, Chapter 2 - Overview of computer-aided drug design for epigenetic targets, in: J.L. Medina-Franco (Ed.), Epi-Informatics, Academic Press, Boston, 2016: pp. 21\u201352. https:\/\/doi.org\/10.1016\/B978-0-12-802808-7.00002-2.","DOI":"10.1016\/B978-0-12-802808-7.00002-2"},{"key":"10.1016\/j.comtox.2021.100191_b0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fchem.2018.00057","article-title":"Computer-aided drug design in epigenetics","volume":"6","author":"Lu","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.comtox.2021.100191_b0525","doi-asserted-by":"crossref","unstructured":"E.E. Somogyvari, S.G. Akl, L.M. Winn, Computational approaches to epigenetic drug discovery, in: A. Adamatzky (Ed.), Emergent Computation\u00a0: A Festschrift for Selim G. Akl, Springer International Publishing, Cham, 2017: pp. 453\u2013465. https:\/\/doi.org\/10.1007\/978-3-319-46376-6_21.","DOI":"10.1007\/978-3-319-46376-6_21"},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0530","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0535","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell."},{"key":"10.1016\/j.comtox.2021.100191_b0540","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.3390\/molecules24213870","article-title":"Replication stress and consequential instability of the genome and epigenome","volume":"24","author":"Tsegay","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.comtox.2021.100191_b0545","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0550","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.comtox.2021.100191_b0555","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fchem.2019.00385","article-title":"Prediction of the antioxidant response elements\u2019 response of compound by deep learning","volume":"7","author":"Bai","year":"2019","journal-title":"Front. Chem."},{"issue":"2-3","key":"10.1016\/j.comtox.2021.100191_b0560","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10629369508029908","article-title":"SAR models for futile metabolism: one-electron reduction of quinones, phenols and nitrobenzenes","volume":"4","author":"Bradbury","year":"1995","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.comtox.2021.100191_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fenvs.2015.00080","article-title":"DeepTox: toxicity prediction using deep learning","volume":"3","author":"Mayr","year":"2016","journal-title":"Front. Environ. Sci."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b0570","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10629369608031715","article-title":"Estimating one-electron reduction potentials of quinones","volume":"5","author":"Mekenyan","year":"1996","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.comtox.2021.100191_b0575","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tiv.2017.10.016","article-title":"Oxidative stress prediction: A preliminary approach using a response surface based technique","volume":"46","author":"Sierra","year":"2018","journal-title":"Toxicol. In Vitro."},{"key":"10.1016\/j.comtox.2021.100191_b0580","doi-asserted-by":"crossref","unstructured":"T.P. Williamson, S. Amirahmadi, G. Joshi, N.K. Kaludov, M.N. Martinov, D.A. Johnson, J.A. Johnson, Discovery of potent, novel Nrf2 inducers via quantum modeling, virtual screening, and in vitro experimental validation, Chem. Biol. Drug Des. 80 (2012) 810\u2013820. https:\/\/doi.org\/10.1111\/cbdd.12040.","DOI":"10.1111\/cbdd.12040"},{"key":"10.1016\/j.comtox.2021.100191_b0585","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00429","article-title":"Investigation of Nrf2, AhR and ATF4 activation in toxicogenomic databases","volume":"9","author":"Zgheib","year":"2018","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0590","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1752-0509-7-41","article-title":"Computational modelling of the regulation of Insulin signalling by oxidative stress","volume":"7","author":"Smith","year":"2013","journal-title":"BMC Syst. Biol."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0595","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/01480545.2014.922096","article-title":"Chemometrics models for assessment of oxidative stress risk in chrome-electroplating workers","volume":"38","author":"Zendehdel","year":"2015","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0600","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tiv.2016.03.003","article-title":"Comparative study on prediction performance of photosafety testing tools on photoallergens","volume":"33","author":"Onoue","year":"2016","journal-title":"Toxicol. In Vitro."},{"key":"10.1016\/j.comtox.2021.100191_b0605","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1386207318666150305144650","article-title":"Prediction of drug induced liver injury using molecular and biological descriptors","volume":"18","author":"Muller","year":"2015","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2008.02.029","article-title":"Determination of hydroperoxides in foods and biological samples by the ferrous oxidation\u2013xylenol orange method: A review of the factors that influence the method\u2019s performance","volume":"377","author":"Bou","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.comtox.2021.100191_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6501046","article-title":"Measurement and clinical significance of biomarkers of oxidative stress in humans","volume":"2017","author":"Marrocco","year":"2017","journal-title":"Oxid. Med. Cell. Longevity."},{"issue":"11","key":"10.1016\/j.comtox.2021.100191_b0620","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tibs.2013.08.009","article-title":"Recent advances in reactive oxygen species measurement in biological systems","volume":"38","author":"Woolley","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.comtox.2021.100191_b0625","doi-asserted-by":"crossref","unstructured":"J. Hancock, M. Conway, eds., Redox-mediated signal transduction, 2nd edition, Humana Press, New York, 2019. https:\/\/doi.org\/10.1007\/978-1-4939-9463-2.","DOI":"10.1007\/978-1-4939-9463-2"},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0630","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/685547","article-title":"Reactive Oxygen Species\u2013associated molecular signature predicts survival in patients with sepsis","volume":"6","author":"Bime","year":"2016","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.comtox.2021.100191_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mutage\/gex046","article-title":"The comet assay: ready for 30 more years","volume":"33","author":"M\u00f8ller","year":"2018","journal-title":"Mutagenesis."},{"key":"10.1016\/j.comtox.2021.100191_b0640","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0645","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0278-6915(96)00048-8","article-title":"Contribution of phenols, quinones and reactive oxygen species to the mutagenicity of white grape juice in the Ames test","volume":"34","author":"Patrineli","year":"1996","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0650","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/mutage\/5.3.285","article-title":"Comparison of Salmonella Typhimurium TA102 with Escherichia coli WP2 tester strains","volume":"5","author":"Wilcox","year":"1990","journal-title":"Mutagenesis"},{"key":"10.1016\/j.comtox.2021.100191_b0655","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13059-018-1411-7","article-title":"Predicting double-strand DNA breaks using epigenome marks or DNA at kilobase resolution","volume":"19","author":"Mourad","year":"2018","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.comtox.2021.100191_b0660","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/bph.13673","article-title":"Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches","volume":"174","author":"Cipak Gasparovic","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0665","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"issue":"14","key":"10.1016\/j.comtox.2021.100191_b0670","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/ars.2015.6317","article-title":"Clinical relevance of biomarkers of oxidative stress","volume":"23","author":"Frijhoff","year":"2015","journal-title":"Antioxid. Redox Signaling."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b0675","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1289\/ehp.1509763","article-title":"Mechanism profiling of hepatotoxicity caused by oxidative stress using antioxidant response element reporter gene assay models and big data","volume":"124","author":"Kim","year":"2016","journal-title":"Environ. Health Perspect."},{"issue":"8","key":"10.1016\/j.comtox.2021.100191_b0680","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1289\/ehp.1104709","article-title":"Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach","volume":"120","author":"Shukla","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.comtox.2021.100191_b0685","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4939-6346-1_6","article-title":"Cell-based assay for identifying the modulators of antioxidant response element signaling pathway","volume":"1473","author":"Zhao","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.comtox.2021.100191_b0690","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1568009618666181018162549","article-title":"Gender differences in the antioxidant response to oxidative stress in experimental brain tumors","volume":"19","author":"Ram\u00edrez-Exp\u00f3sito","year":"2019","journal-title":"Curr. Cancer Drug Targets."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0695","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nprot.2009.197","article-title":"Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue","volume":"5","author":"Weydert","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.comtox.2021.100191_b0700","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2017.08.008","article-title":"Assessment of glutathione\/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells","volume":"112","author":"Giustarini","year":"2017","journal-title":"Free Radical Biol. Med."},{"issue":"7203","key":"10.1016\/j.comtox.2021.100191_b0705","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.comtox.2021.100191_b0710","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.2174\/138161212802083707","article-title":"Molecular link mechanisms between inflammation and cancer","volume":"18","author":"Vendramini-Costa","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.comtox.2021.100191_b0715","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fonc.2012.00058","article-title":"Radiation, inflammation, and immune responses in cancer","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front. Oncol."},{"issue":"6917","key":"10.1016\/j.comtox.2021.100191_b0720","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0725","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity."},{"key":"10.1016\/j.comtox.2021.100191_b0730","unstructured":"A. Kane, Inflammation - Chapter 17, in: R.A. Baan, B.W. Stewart, K. Straif (Eds.), Tumour Site Concordance and Mechanisms of Carcinogenesis, WHO Press, World Health Organization, Switzerland, 2019. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Scientific-Publications\/Tumour-Site-Concordance-And-Mechanisms-Of-Carcinogenesis-2019."},{"issue":"11","key":"10.1016\/j.comtox.2021.100191_b0735","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ni.3828","article-title":"Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities","volume":"18","author":"Liu","year":"2017","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0740","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2013.08.014","article-title":"Molecular mechanisms underlying chronic inflammation-associated cancers","volume":"345","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0745","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.rpor.2020.04.004","article-title":"Interplay between inflammation and cancer","volume":"25","author":"Piotrowski","year":"2020","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.comtox.2021.100191_b0750","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2011.00098","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0755","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1158\/1055-9965.EPI-14-0064","article-title":"A review of the application of inflammatory biomarkers in epidemiologic cancer research, Cancer Epidemiol","volume":"23","author":"Brenner","year":"2014","journal-title":"Biomarkers Prev."},{"issue":"12","key":"10.1016\/j.comtox.2021.100191_b0760","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.comtox.2021.100191_b0765","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/ijc.30194","article-title":"Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population","volume":"139","author":"Allin","year":"2016","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.comtox.2021.100191_b0770","doi-asserted-by":"crossref","first-page":"51","DOI":"10.14573\/altex.1703231","article-title":"Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups","volume":"35","author":"Chiu","year":"2018","journal-title":"ALTEX."},{"key":"10.1016\/j.comtox.2021.100191_b0775","series-title":"Small-Molecule Transcription Factor Inhibitors in Oncology","article-title":"Computational approaches in the development of small-molecule transcription factor inhibitors","author":"Jackson","year":"2018"},{"key":"10.1016\/j.comtox.2021.100191_b0780","doi-asserted-by":"crossref","unstructured":"M. Miyasaka, K. Takatsu, eds., Chronic inflammation, Springer Japan, Tokyo, 2016. https:\/\/doi.org\/10.1007\/978-4-431-56068-5.","DOI":"10.1007\/978-4-431-56068-5"},{"key":"10.1016\/j.comtox.2021.100191_b0785","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yrtph.2015.12.018","article-title":"HESI\/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach","volume":"75","author":"Lebrec","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b0790","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cotox.2018.06.002","article-title":"Immunomodulation and cancer: Using mechanistic paradigms to inform risk assessment","volume":"10","author":"Ponce","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"issue":"11","key":"10.1016\/j.comtox.2021.100191_b0795","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0800","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int. J. Cancer."},{"issue":"7203","key":"10.1016\/j.comtox.2021.100191_b0805","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b0810","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat. Rev. Cancer."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b0815","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1091581810374654","article-title":"Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia","volume":"29","author":"Bugelski","year":"2010","journal-title":"Int. J. Toxicol."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b0820","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/oemed-2020-106517","article-title":"Benzene-associated immunosuppression and chronic inflammation in humans: a systematic review","volume":"78","author":"Guo","year":"2021","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.comtox.2021.100191_b0825","unstructured":"FDA, FDA draft nonclinical safety evaluation of the immunotoxic potential of drugs and biologics - Guidance for industry, in: Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, 2020. https:\/\/www.fda.gov\/media\/135312\/download."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0830","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0300985811400445","article-title":"A critical review of the effectiveness of rodent pharmaceutical carcinogenesis testing in predicting for human risk","volume":"48","author":"Alden","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.comtox.2021.100191_b0835","series-title":"Tumour Site Concordance and Mechanisms of Carcinogenesis","article-title":"Receptor-mediated mechanisms - Chapter 14","author":"Bosland","year":"2019"},{"key":"10.1016\/j.comtox.2021.100191_b0840","unstructured":"M.F. Roberts, A.E. Kruchten, Introduction, in: Receptor Biology, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2016. https:\/\/www.academia.edu\/30128984\/Receptor_Biology (accessed September 30, 2020)."},{"key":"10.1016\/j.comtox.2021.100191_b0845","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/carcin\/bgy031","article-title":"Application of the key characteristics of carcinogens in cancer hazard identification","volume":"39","author":"Guyton","year":"2018","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.comtox.2021.100191_b0850","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b0855","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2017.102","article-title":"Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis","volume":"19","author":"Dhiman","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.comtox.2021.100191_b0860","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrendo.2012.100","article-title":"Nuclear receptor coregulators: modulators of pathology and therapeutic targets","volume":"8","author":"Lonard","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.comtox.2021.100191_b0865","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ctrv.2014.03.004","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in estrogen receptor-positive breast cancer","volume":"40","author":"Ciruelos Gil","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.comtox.2021.100191_b0870","doi-asserted-by":"crossref","unstructured":"M. Llaurad\u00f3, A. Ruiz, B. Majem, T. Ertekin, E. Col\u00e1s, N. Pedrola, L. Devis, M. Rigau, T. Sequeiros, M. Montes, M. Garcia, S. Cabrera, A. Gil-Moreno, J. Xercavins, J. Castellv\u00ed, A. Garcia, S. Ram\u00f3n y Cajal, G. Moreno, F. Alameda, M. V\u00e1zquez-Levin, J. Palacios, J. Prat, A. Doll, X. Mat\u00edas-Guiu, M. Abal, J. Revent\u00f3s, Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease, Mol. Cell. Endocrinol. 358 (2012) 244\u2013255. https:\/\/doi.org\/10.1016\/j.mce.2011.10.003.","DOI":"10.1016\/j.mce.2011.10.003"},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0875","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-med-051418-060357","article-title":"Sex hormones and prostate cancer","volume":"71","author":"Auchus","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.comtox.2021.100191_b0880","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1210\/en.2019-00486","article-title":"Is testicular germ cell cancer estrogen dependent? The role of endocrine disrupting chemicals","volume":"160","author":"F\u00e9nichel","year":"2019","journal-title":"Endocrinology."},{"key":"10.1016\/j.comtox.2021.100191_b0885","doi-asserted-by":"crossref","first-page":"T13","DOI":"10.1530\/ERC-13-0342","article-title":"Endocrine disruption of oestrogen action and female reproductive tract cancers","volume":"21","author":"Gibson","year":"2014","journal-title":"Endocr.-Relat Cancer."},{"key":"10.1016\/j.comtox.2021.100191_b0890","first-page":"562","article-title":"Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers","volume":"126","author":"Rutkowska","year":"2016","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.comtox.2021.100191_b0895","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2016.05.007","article-title":"Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement","volume":"165","author":"Morgan","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0900","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/kfv168","article-title":"Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor","volume":"148","author":"Judson","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b0905","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/acs.chemrestox.6b00347","article-title":"Development and validation of a computational model for androgen receptor activity","volume":"30","author":"Kleinstreuer","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0910","doi-asserted-by":"crossref","first-page":"114630","DOI":"10.1016\/j.taap.2019.114630","article-title":"Predicting estrogen receptor binding of chemicals using a suite of in silico methods - Complementary approaches of (Q)SAR, molecular docking and molecular dynamics","volume":"378","author":"Cotterill","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.comtox.2021.100191_b0915","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1021\/acs.chemrestox.5b00260","article-title":"Large-scale predictive drug safety: from structural alerts to biological mechanisms","volume":"28","author":"Garcia-Serna","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0920","unstructured":"IRCSS, VEGA HUB, Istituto di Ricerche Farmacologiche Mario Negri, https:\/\/www.vegahub.eu\/, 2020."},{"key":"10.1016\/j.comtox.2021.100191_b0925","unstructured":"OECD, The OECD QSAR Toolbox, Toolbox 4.4, https:\/\/www.oecd.org\/chemicalsafety\/risk-assessment\/oecd-qsar-toolbox.htm, 2020. https:\/\/www.oecd.org\/chemicalsafety\/risk-assessment\/oecd-qsar-toolbox.htm."},{"key":"10.1016\/j.comtox.2021.100191_b0930","doi-asserted-by":"crossref","DOI":"10.11131\/2016\/101203","article-title":"QSAR methods to screen endocrine disruptors","volume":"3","author":"Porta","year":"2016","journal-title":"Nucl. Recept. Res."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0935","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.taap.2012.03.018","article-title":"VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural products","volume":"261","author":"Vedani","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b0940","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/10408444.2020.1841732","article-title":"Towards a mechanism-based approach for the prediction of nongenotoxic carcinogenic potential of agrochemicals","volume":"50","author":"Heusinkveld","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2017.11.003","article-title":"Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action","volume":"92","author":"Felter","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"46","key":"10.1016\/j.comtox.2021.100191_b0950","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1038\/onc.2008.213","article-title":"Critical pathways in cellular senescence and immortalization revealed by gene expression profiling","volume":"27","author":"Fridman","year":"2008","journal-title":"Oncogene."},{"issue":"Suppl 1","key":"10.1016\/j.comtox.2021.100191_b0955","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/carcin\/bgv029","article-title":"Disruptive chemicals, senescence and immortality","volume":"36","author":"Carnero","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.comtox.2021.100191_b0960","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/carcin\/21.3.477","article-title":"The role of senescence and immortalization in carcinogenesis","volume":"21","author":"Reddel","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.comtox.2021.100191_b0965","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2010.897","article-title":"Telomere length and risk of incident cancer and cancer mortality","volume":"304","author":"Willeit","year":"2010","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b0970","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/onc.2012.45","article-title":"Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells","volume":"32","author":"Yasaei","year":"2013","journal-title":"Oncogene."},{"key":"10.1016\/j.comtox.2021.100191_b0975","series-title":"The History of Alternative Test Methods in Toxicology","first-page":"209","article-title":"Chapter 3.6 - Alternative approaches for carcinogenicity and reproductive toxicity","author":"Corvi","year":"2019"},{"key":"10.1016\/j.comtox.2021.100191_b0980","unstructured":"OECD, Guidance Document on the In Vitro BHAS 42 Cell Transformation Assay, OECD Environment, Health and Safety Publications, Paris, 2016. http:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=ENV\/JM\/MONO(2016)1&docLanguage=En."},{"key":"10.1016\/j.comtox.2021.100191_b0985","unstructured":"OECD, Guidance Document on the In Vitro Syrian Hamster Embryo (SHE) Cell Transformation Assay, OECD Environment, Health and Safety Publications, Paris, 2015. http:\/\/www.oecd.org\/env\/ehs\/testing\/Guidance-Document-on-the-in-vitro-Syrian-Hamster-Embryo-Cell-Transformation-Assay.pdf."},{"key":"10.1016\/j.comtox.2021.100191_b0990","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mrgentox.2015.02.001","article-title":"The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies","volume":"779","author":"Benigni","year":"2015","journal-title":"Mutat. Res., Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b0995","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mutage\/ger053","article-title":"Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs","volume":"27","author":"Creton","year":"2012","journal-title":"Mutagenesis."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1000","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0027-5107(95)00197-2","article-title":"Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals","volume":"356","author":"Isfort","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.comtox.2021.100191_b1005","unstructured":"OECD, Detailed Review Paper On Cell Transformation Assays For Detection Of Chemical Carcinogens, OECD Environment, Health and Safety Publications, Paris, 2007. http:\/\/www.oecd.org\/chemicalsafety\/testing\/series-testing-assessment-publications-number.htm."},{"key":"10.1016\/j.comtox.2021.100191_b1010","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.dib.2018.01.077","article-title":"QSAR ligand dataset for modelling mutagenicity, genotoxicity, and rodent carcinogenicity","volume":"17","author":"Guan","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.comtox.2021.100191_b1015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yrtph.2018.01.008","article-title":"Combining machine learning models of in vitro and in vivo bioassays improves rat carcinogenicity prediction","volume":"94","author":"Guan","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b1020","article-title":"Techniques to induce and quantify cellular senescence","author":"Hooten","year":"2017","journal-title":"J. Visualized Exp."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.32607\/20758251-2011-3-1-48-68","article-title":"Assays for detection of telomerase activity","volume":"3","author":"Skvortsov","year":"2011","journal-title":"Acta Naturae."},{"issue":"13","key":"10.1016\/j.comtox.2021.100191_b1030","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3390\/ijerph16132292","article-title":"Night shift work, DNA methylation and telomere length: an investigation on hospital female nurses","volume":"16","author":"Carugno","year":"2019","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"10.1016\/j.comtox.2021.100191_b1035","doi-asserted-by":"crossref","unstructured":"R.M. Cawthon, Telomere length measurement by a novel monochrome multiplex quantitative PCR method, Nucleic Acids Res. 37 (2009) e21. https:\/\/doi.org\/10.1093\/nar\/gkn1027.","DOI":"10.1093\/nar\/gkn1027"},{"issue":"8","key":"10.1016\/j.comtox.2021.100191_b1040","doi-asserted-by":"crossref","first-page":"e23462","DOI":"10.1371\/journal.pone.0023462","article-title":"Associations between rotating night shifts, sleep duration, and telomere length in women","volume":"6","author":"Liang","year":"2011","journal-title":"PLoS ONE."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b1045","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/mp.2017.26","article-title":"Early life adversity and telomere length: a meta-analysis","volume":"23","author":"Ridout","year":"2018","journal-title":"Mol. Psychiatry."},{"issue":"12","key":"10.1016\/j.comtox.2021.100191_b1050","doi-asserted-by":"crossref","first-page":"e48677","DOI":"10.1371\/journal.pone.0048677","article-title":"Morphologic and gene expression criteria for identifying human induced pluripotent stem cells","volume":"7","author":"Wakao","year":"2012","journal-title":"PLoS ONE."},{"issue":"5-6","key":"10.1016\/j.comtox.2021.100191_b1055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygeno.2017.05.006","article-title":"In vitro effects of reprogramming factors on the expressions of pluripotent genes and CD34 gene in human acute promyelocytic leukemia HL-60 cells","volume":"109","author":"Zhu","year":"2017","journal-title":"Genomics."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b1060","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/cas.12734","article-title":"Susceptibility of pancreatic cancer stem cells to reprogramming","volume":"106","author":"Noguchi","year":"2015","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.comtox.2021.100191_b1065","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.comtox.2021.100191_b1070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/502676","article-title":"The impact of autophagy on cell death modalities","volume":"2014","author":"Ryter","year":"2014","journal-title":"Int. J. Cell Biol."},{"issue":"6117","key":"10.1016\/j.comtox.2021.100191_b1075","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.1232227","article-title":"Neutralizing tumor-promoting chronic inflammation: a magic bullet?","volume":"339","author":"Coussens","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b1080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003285","article-title":"Leukocytes in mammary development and cancer","volume":"3","author":"Coussens","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b1085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1189\/jlb.1107762","article-title":"Macrophages define the invasive microenvironment in breast cancer","volume":"84","author":"Pollard","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.comtox.2021.100191_b1090","doi-asserted-by":"crossref","first-page":"856","DOI":"10.15252\/embj.201490784","article-title":"Autophagy in malignant transformation and cancer progression","volume":"34","author":"Galluzzi","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.comtox.2021.100191_b1095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000163596","article-title":"Chemical, oncogene and growth factor inhibition gap junctional intercellular communication: an integrative hypothesis of carcinogenesis","volume":"58","author":"Trosko","year":"1990","journal-title":"Pathobiology"},{"key":"10.1016\/j.comtox.2021.100191_b1100","doi-asserted-by":"crossref","first-page":"d208","DOI":"10.2741\/A275","article-title":"Cell-cell communication in carcinogenesis","volume":"3","author":"Trosko","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.comtox.2021.100191_b1105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/carcin\/11.7.1051","article-title":"Gap junctional intercellular communication and carcinogenesis","volume":"11","author":"Yamasaki","year":"1990","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2016.07.037","article-title":"Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis","volume":"381","author":"Mao","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.comtox.2021.100191_b1115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fonc.2018.00646","article-title":"Cancer connectors: connexins, gap junctions, and communication","volume":"8","author":"Sinyuk","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.comtox.2021.100191_b1120","series-title":"Carcinogenicity: Testing, Predicting, and Interpreting Chemical Effects","first-page":"267","article-title":"Gap junctional intercellular communication as a method to detect and predict carcinogenicity","author":"Krutovskikh","year":"1999"},{"key":"10.1016\/j.comtox.2021.100191_b1125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/carcin\/21.5.1007","article-title":"Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena","volume":"21","author":"Rosenkranz","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.comtox.2021.100191_b1130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/toxsci\/71.2.146","article-title":"Disruption of gap junctions in toxicity and carcinogenicity","volume":"71","author":"Chipman","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b1135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3835(84)90173-3","article-title":"Phorbol ester tumor promoter affects the mouse epidermal gap junctions","volume":"22","author":"Kalimi","year":"1984","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b1140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/carcin\/15.4.689","article-title":"Inhibition of gap junctional intercellular communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT","volume":"15","author":"Rivedal","year":"1994","journal-title":"Carcinogenesis"},{"issue":"4422","key":"10.1016\/j.comtox.2021.100191_b1145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.493994","article-title":"Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter","volume":"206","author":"Yotti","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.comtox.2021.100191_b1150","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/cells8080896","article-title":"Gap junction intercellular communication in the carcinogenesis hallmarks: is this a phenomenon or epiphenomenon?","volume":"8","author":"Zefferino","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.comtox.2021.100191_b1155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/ijms.5344","article-title":"Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Akt2 inhibitors","volume":"10","author":"Fei","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.comtox.2021.100191_b1160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2105-13-186","article-title":"Integrated QSAR study for inhibitors of Hedgehog Signal Pathway against multiple cell lines: a collaborative filtering method","volume":"13","author":"Gao","year":"2012","journal-title":"BMC Bioinformatics."},{"key":"10.1016\/j.comtox.2021.100191_b1165","first-page":"1","article-title":"Linear and nonlinear QSAR study of N2 and O6 substituted guanine derivatives as cyclin-dependent kinase 2 inhibitors, ISRN","volume":"2013","author":"Goudarzi","year":"2013","journal-title":"Anal. Chem."},{"issue":"21","key":"10.1016\/j.comtox.2021.100191_b1170","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.3390\/molecules24213909","article-title":"Multi-target chemometric modelling, fragment analysis and virtual screening with ERK inhibitors as potential anticancer agents","volume":"24","author":"Halder","year":"2019","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.comtox.2021.100191_b1175","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3390\/ijms20174191","article-title":"Development of multi-target chemometric models for the inhibition of class I PI3K enzyme isoforms: a case study using QSAR-Co tool","volume":"20","author":"Halder","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.comtox.2021.100191_b1180","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.2147\/OTT.S108526","article-title":"Structure-activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches","volume":"9","author":"Lakhlili","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b1185","doi-asserted-by":"crossref","first-page":"e0124244","DOI":"10.1371\/journal.pone.0124244","article-title":"Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors","volume":"10","author":"Zanni","year":"2015","journal-title":"PLoS ONE."},{"issue":"8","key":"10.1016\/j.comtox.2021.100191_b1190","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.arabjc.2016.12.007","article-title":"Synthesis, in vitro evaluation and QSAR modelling of potential antitumoral 3,4-dihydropyrimidin-2-(1H)-thiones","volume":"12","author":"Matias","year":"2019","journal-title":"Arabian J. Chem."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b1195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.chemolab.2011.04.011","article-title":"QSAR treatment on a new class of triphenylmethyl-containing compounds as potent anticancer agents","volume":"107","author":"Mullen","year":"2011","journal-title":"Chemom. Intell. Lab. Syst."},{"issue":"16","key":"10.1016\/j.comtox.2021.100191_b1200","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/15287390802114337","article-title":"Using quantitative structure-activity relationships (QSAR) to predict toxic endpoints for polycyclic aromatic hydrocarbons (PAH)","volume":"71","author":"Bruce","year":"2008","journal-title":"J. Toxicol. Environ. Health Part A"},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxlet.2008.06.870","article-title":"Prediction of the health effects of polychlorinated biphenyls (PCBs) and their metabolites using quantitative structure\u2013activity relationship (QSAR)","volume":"181","author":"Ruiz","year":"2008","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b1210","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.chemosphere.2011.08.019","article-title":"Multivariate toxicity profiles and QSAR modeling of non-dioxin-like PCBs\u2013an investigation of in vitro screening data from ultra-pure congeners","volume":"85","author":"Stenberg","year":"2011","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.comtox.2021.100191_b1215","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/0192623315576005","article-title":"Scientific and Regulatory Policy Committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment","volume":"43","author":"Wood","year":"2015","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.2002.5537","article-title":"Nuclear apoptosis detection by flow cytometry: influence of endogenous endonucleases","volume":"277","author":"Lecoeur","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.comtox.2021.100191_b1225","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3892\/ijo.2017.4118","article-title":"Measuring the response of human head and neck squamous cell carcinoma to irradiation in a microfluidic model allowing customized therapy","volume":"51","author":"Cheah","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.comtox.2021.100191_b1230","unstructured":"T.L. Riss, R.A. Moravec, A.L. Niles, S. Duellman, H.A. Benink, T.J. Worzella, L. Minor, Cell viability assays, in: S. Markossian, G.S. Sittampalam, A. Grossman, K. Brimacombe, M. Arkin, D. Auld, C.P. Austin, J. Baell, J.M.M. Caaveiro, T.D.Y. Chung, N.P. Coussens, J.L. Dahlin, V. Devanaryan, T.L. Foley, M. Glicksman, M.D. Hall, J.V. Haas, S.R.J. Hoare, J. Inglese, P.W. Iversen, S.D. Kahl, S.C. Kales, S. Kirshner, M. Lal-Nag, Z. Li, J. McGee, O. McManus, T. Riss, P. Saradjian, O.J. Trask, J.R. Weidner, M.J. Wildey, M. Xia, X. Xu (Eds.), Assay Guidance Manual, Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda (MD), 2013. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK144065\/."},{"issue":"2","key":"10.1016\/j.comtox.2021.100191_b1235","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ab.2009.09.029","article-title":"Comparison of methods for measuring oxygen consumption in tumor cells in vitro","volume":"396","author":"Diepart","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.comtox.2021.100191_b1240","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2850","article-title":"Measurement of Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) in culture cells for assessment of the energy metabolism","volume":"8","author":"Plitzko","year":"2018","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.comtox.2021.100191_b1245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.redox.2017.09.020","article-title":"A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds","volume":"14","author":"Kalyanaraman","year":"2018","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b1250","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10522-016-9655-7","article-title":"AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms","volume":"17","author":"Salminen","year":"2016","journal-title":"Biogerontology."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1255","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00247.2006","article-title":"Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells","volume":"292","author":"Wu","year":"2007","journal-title":"Am. J. Physiol.: Cell Physiol."},{"key":"10.1016\/j.comtox.2021.100191_b1260","doi-asserted-by":"crossref","first-page":"104655","DOI":"10.1016\/j.yrtph.2020.104655","article-title":"Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide","volume":"113","author":"LaRocca","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.comtox.2021.100191_b1265","doi-asserted-by":"crossref","first-page":"e0153813","DOI":"10.1371\/journal.pone.0153813","article-title":"Electric cell-substrate impedance sensing (ECIS) with microelectrode arrays for investigation of cancer cell-fibroblasts interaction","volume":"11","author":"Tran","year":"2016","journal-title":"PLoS ONE."},{"key":"10.1016\/j.comtox.2021.100191_b1270","series-title":"Silico Methods for Predicting Drug Toxicity","first-page":"325","article-title":"Adverse outcome pathways as tools to assess drug-induced toxicity","author":"Vinken","year":"2016"},{"issue":"9","key":"10.1016\/j.comtox.2021.100191_b1275","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/carcin\/12.9.1701","article-title":"Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo","volume":"12","author":"Krutovskikh","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.comtox.2021.100191_b1280","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/carcin\/21.9.1671","article-title":"Prevention of the down-regulation of gap junctional intercellular communication by green tea in the liver of mice fed pentachlorophenol","volume":"21","author":"Sai","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.comtox.2021.100191_b1285","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9","article-title":"Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail","volume":"78","author":"Upham","year":"1998","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.comtox.2021.100191_b1290","unstructured":"FDA, FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market, FDA. (2020). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market (accessed October 19, 2020)."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b1295","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1289\/ehp.0800168","article-title":"The toxicity data landscape for environmental chemicals","volume":"117","author":"Judson","year":"2009","journal-title":"Environ. Health Perspect."},{"issue":"12","key":"10.1016\/j.comtox.2021.100191_b1300","doi-asserted-by":"crossref","first-page":"125003","DOI":"10.1289\/EHP5672","article-title":"New perspectives for cancer hazard evaluation by the report on carcinogens: a case study using read-across methods in the evaluation of haloacetic acids found as water disinfection by-products","volume":"127","author":"Atwood","year":"2019","journal-title":"Environ. Health Perspect."},{"issue":"6","key":"10.1016\/j.comtox.2021.100191_b1305","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00204-021-03035-x","article-title":"Integration of data across toxicity endpoints for improved safety assessment of chemicals: the example of carcinogenicity assessment","volume":"95","author":"Madia","year":"2021","journal-title":"Arch Toxicol."},{"issue":"11","key":"10.1016\/j.comtox.2021.100191_b1310","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1021\/acssuschemeng.6b02089","article-title":"Current status and future challenges in molecular design for reduced hazard","volume":"4","author":"Coish","year":"2016","journal-title":"ACS Sustainable Chem. Eng."},{"issue":"6476","key":"10.1016\/j.comtox.2021.100191_b1315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.aay3060","article-title":"Designing for a green chemistry future","volume":"367","author":"Zimmerman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.comtox.2021.100191_b1320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/toxsci\/kfz017","article-title":"An integrated approach using publicly available resources for identifying and characterizing chemicals of potential toxicity concern: proof-of-concept with chemicals that affect cancer pathways","volume":"169","author":"Iyer","year":"2019","journal-title":"Toxicol Sci."},{"issue":"5","key":"10.1016\/j.comtox.2021.100191_b1325","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00204-020-02774-7","article-title":"Quantitative adverse outcome pathway (qAOP) models for toxicity prediction","volume":"94","author":"Spinu","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.comtox.2021.100191_b1330","article-title":"Identification of early warning signals at the critical transition point of colorectal cancer based on dynamic network analysis","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.comtox.2021.100191_b1335","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41467-018-03024-2","article-title":"Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma","volume":"9","author":"Yang","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.comtox.2021.100191_b1340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgp261","article-title":"Cancer systems biology: a network modeling perspective","volume":"31","author":"Kreeger","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.comtox.2021.100191_b1345","doi-asserted-by":"crossref","first-page":"104592","DOI":"10.1016\/j.yrtph.2020.104592","article-title":"An evaluation framework for new approach methodologies (NAMs) for human health safety assessment","volume":"112","author":"Parish","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b1350","doi-asserted-by":"crossref","first-page":"104789","DOI":"10.1016\/j.yrtph.2020.104789","article-title":"A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals","volume":"118","author":"Luijten","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100191_b1355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.14573\/altex.1608281","article-title":"Uncertainties of testing methods: What do we (want to) know about carcinogenicity?","volume":"34","author":"Paparella","year":"2017","journal-title":"ALTEX."},{"key":"10.1016\/j.comtox.2021.100191_b1360","series-title":"Silico Methods for Predicting Drug Toxicity","first-page":"63","article-title":"Modeling ADMET","author":"Ghosh","year":"2016"},{"key":"10.1016\/j.comtox.2021.100191_b1365","doi-asserted-by":"crossref","unstructured":"J.C. Madden, In Silico Approaches for Predicting ADME Properties, in: T. Puzyn, J. Leszczynski, M.T. Cronin (Eds.), Recent Advances in QSAR Studies, Springer, Dordrecht, 2010: pp. 283\u2013304. https:\/\/doi.org\/10.1007\/978-1-4020-9783-6_10.","DOI":"10.1007\/978-1-4020-9783-6_10"},{"key":"10.1016\/j.comtox.2021.100191_b1370","article-title":"Review of QSAR models and software tools for predicting biokinetic properties","author":"Mostrag-Szlichtyng","year":"2010","journal-title":"Luxembourg"},{"key":"10.1016\/j.comtox.2021.100191_b1375","series-title":"Handbook of Computational Chemistry","first-page":"1","article-title":"Predicting ADME Properties of Chemicals","author":"Shin","year":"2016"},{"key":"10.1016\/j.comtox.2021.100191_b1380","doi-asserted-by":"crossref","unstructured":"W.B. Coleman, Neoplasia, in: W.B. Coleman, G.J. Tsongalis (Eds.), Molecular Pathology, 2nd Edition, Elsevier, 2018: pp. 71\u201397. https:\/\/doi.org\/10.1016\/B978-0-12-802761-5.00004-3.","DOI":"10.1016\/B978-0-12-802761-5.00004-3"},{"key":"10.1016\/j.comtox.2021.100191_b1385","doi-asserted-by":"crossref","unstructured":"F. Feo, Preneoplastic lesions, in: M. Schwab (Ed.), Encyclopedia of Cancer, Springer Berlin Heidelberg, Berlin, Heidelberg, 2011: pp. 2977\u20132984. https:\/\/doi.org\/10.1007\/978-3-642-16483-5_4724.","DOI":"10.1007\/978-3-642-16483-5_4724"},{"key":"10.1016\/j.comtox.2021.100191_b1390","doi-asserted-by":"crossref","unstructured":"D.E. Malarkey, M.J. Hoenerhoff, R.R. Maronpot, Carcinogenesis: manifestation and mechanism, in: Fundamentals of Toxicologic Pathology, Elsevier, 2018: pp. 83\u2013104. https:\/\/doi.org\/10.1016\/B978-0-12-809841-7.00006-X.","DOI":"10.1016\/B978-0-12-809841-7.00006-X"},{"key":"10.1016\/j.comtox.2021.100191_b1395","unstructured":"IARC, Some organophosphate insecticides and herbicides, WHO Press, World Health Organization, Switzerland, 2017. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Some-Organophosphate-Insecticides-And-Herbicides-2017."}],"container-title":["Computational Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468111321000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468111321000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:47:05Z","timestamp":1762836425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468111321000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":279,"alternative-id":["S2468111321000396"],"URL":"https:\/\/doi.org\/10.1016\/j.comtox.2021.100191","relation":{},"ISSN":["2468-1113"],"issn-type":[{"value":"2468-1113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico approaches in carcinogenicity hazard assessment: Current status and future needs","name":"articletitle","label":"Article Title"},{"value":"Computational Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comtox.2021.100191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100191"}}